Literature DB >> 17666361

Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome.

Marie Robin1, Stéphanie Marque-Juillet, Catherine Scieux, Régis Peffault de Latour, Christèle Ferry, Vanderson Rocha, Jean-Michel Molina, Anne Bergeron, Agnès Devergie, Eliane Gluckman, Patricia Ribaud, Gérard Socié.   

Abstract

We analyzed the factors and outcome of patients with disseminated adenovirus infection (dAdV) after allogeneic hematopoeitic stem cell transplantation (HSCT). Thirty patients with dAdV were identified among 620 allogeneic HSCT recipients. Primary diseases were leukemia (n=17), Fanconi anemia (n=12) or others (n=1). Source of stem cells was unrelated in 28 and related in 2 patients. The graft consisted of peripheral blood (n=3), bone marrow (n=12) and unrelated cord-blood (UCB, n=15). Risk factors for dAdV in unrelated HSCT recipients were previous Fanconi disease (p=0.03) and GVHD (p=0.02) in children, and cord blood source of stem cells (p=0.029) and GVHD (0.024) in adults.

Entities:  

Mesh:

Year:  2007        PMID: 17666361     DOI: 10.3324/haematol.11279

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  35 in total

1.  Comparison of in-house real-time quantitative PCR to the Adenovirus R-Gene kit for determination of adenovirus load in clinical samples.

Authors:  Hélène Jeulin; Alexandra Salmon; Pierre Bordigoni; Véronique Venard
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

2.  Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact.

Authors:  Yeon Joo Lee; Yao-Ting Huang; Seong Jin Kim; Molly Maloy; Roni Tamari; Sergio A Giralt; Esperanza B Papadopoulos; Ann A Jakubowski; Genovefa A Papanicolaou
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-28       Impact factor: 5.742

3.  Adenoviral infection presenting as an isolated central nervous system disease without detectable viremia in two children after stem cell transplantation.

Authors:  Pierre Frange; Régis Peffault de Latour; Cécile Arnaud; Nathalie Boddaert; Mehdi Oualha; Véronique Avettand-Fenoel; Françoise Bernaudin; Claire Aguilar; Christine Barnerias; Marianne Leruez-Ville; Fabien Touzot; Olivier Lortholary; Alain Fischer; Stéphane Blanche
Journal:  J Clin Microbiol       Date:  2011-04-13       Impact factor: 5.948

Review 4.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

Review 5.  Adenovirus infections in immunocompetent and immunocompromised patients.

Authors:  Thomas Lion
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

6.  Persistent recipient-derived human adenovirus (HAdV)-specific T cells promote HAdV control after allogeneic hematopoietic stem cell transplantation.

Authors:  R E Schultze-Florey; S Tischer; W Kühnau; A Heim; B Eiz-Vesper; B Maecker-Kolhoff
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

7.  Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis.

Authors:  Worawut Choeyprasert; Suradej Hongeng; Usanarat Anurathapan; Samart Pakakasama
Journal:  Int J Hematol       Date:  2016-10-22       Impact factor: 2.490

8.  Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin.

Authors:  Craig Sauter; Michelle Abboud; Xiaoyu Jia; Glenn Heller; Anne-Marie Gonzales; Marissa Lubin; Rebecca Hawke; Miguel-Angel Perales; Marcel R van den Brink; Sergio Giralt; Genovefa Papanicolaou; Andromachi Scaradavou; Trudy N Small; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2011-03-01       Impact factor: 5.742

9.  Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.

Authors:  Yeon Joo Lee; Dick Chung; Kun Xiao; Esperanza B Papadopoulos; Juliet N Barker; Trudy N Small; Sergio A Giralt; Junting Zheng; Ann A Jakubowski; Genovefa A Papanicolaou
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-22       Impact factor: 5.742

10.  Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients.

Authors:  Cedar J Fowler; Jennifer Dunlap; Darcy Troyer; Peter Stenzel; Elliot Epner; Richard T Maziarz
Journal:  Adv Hematol       Date:  2010-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.